Drug Database
Back to search

United States· US:53746-248_acd7e4c4-f9c9-4dae-b42e-e25622de9921

Alosetron Hydrochloride

A alosetron product containing alosetron hydrochloride, registered in United States by Amneal Pharmaceuticals of New York LLC.

ATC A03AE01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAlosetron HydrochlorideATCA03AE01REGISTER NO.US:53746-248_acd7e4c4…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alosetron hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ALOSETRON HYDROCHLORIDE
Manufacturer
Amneal Pharmaceuticals of New York LLC
Country
United States (US)
ATC code
A03AE01
ATC class
Alosetron
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    53746-248-30
  • ndc11
    5374624830
    30 TABLET, FILM COATED in 1 BOTTLE (53746-248-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

156 interactions on record for alosetron.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alosetron against other medicinesHow interaction checks work

Alosetron · interactions on record

156 records

  • 4 severe
  • 64 moderate
  • 2 minor
  • 86 info

Most severe, free to view

  • ApomorphineG04BE07severe
  • ApomorphineN04BC07severe
  • FluvoxamineN06AB08severe
  • ApomorphinV03AB45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A03AE01

Alosetron, as other registers publish it.

All alosetron products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6a786e05-4ae7-4543-be59-81ac32db1a70
GET /v1/drugs/6a786e05-4ae7-4543-be59-81ac32db1a70?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": ".5",
  "substance": "ALOSETRON HYDROCHLORIDE",
  "productndc": "53746-248",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA206647",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about alosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console